Introduction: Cancer Stem Cells

[1]  Lihong Hu,et al.  A 20(S)-protopanoxadiol derivative overcomes multi-drug resistance by antagonizing ATP-binding cassette subfamily B member 1 transporter function , 2016, Oncotarget.

[2]  Chi-Ping Day,et al.  Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges , 2015, Cell.

[3]  Yuting Xu,et al.  TPO-Induced Metabolic Reprogramming Drives Liver Metastasis of Colorectal Cancer CD110+ Tumor-Initiating Cells. , 2015, Cell stem cell.

[4]  Francisco J. Sánchez-Rivera,et al.  Applications of the CRISPR–Cas9 system in cancer biology , 2015, Nature Reviews Cancer.

[5]  S. Inoue,et al.  Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. , 2015, Cancer cell.

[6]  Yau-Huei Wei,et al.  Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma , 2015, Cell cycle.

[7]  Philip Levy Ho,et al.  Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance , 2014, Nature.

[8]  J. Wolchok,et al.  Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.

[9]  C. Deng.  Conditional knockout mouse models of cancer. , 2014, Cold Spring Harbor protocols.

[10]  T. Lawrence,et al.  Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in mice. , 2014, Gastroenterology.

[11]  A. Palucka,et al.  Development and function of human innate immune cells in a humanized mouse model , 2014, Nature Biotechnology.

[12]  R. Puri,et al.  Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma , 2014, BMC Cancer.

[13]  K. Jensen,et al.  Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III. , 2014, Cancer research.

[14]  A. Cittadini,et al.  Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives. , 2014, World journal of gastroenterology.

[15]  William A. Flavahan,et al.  High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor. , 2014, Cell reports.

[16]  M. Bouvet,et al.  In vivo serial selection of human pancreatic cancer cells in orthotopic mouse models produces high metastatic variants irrespective of Kras status. , 2013, The Journal of surgical research.

[17]  N. Gellrich,et al.  Functional features of cancer stem cells in melanoma cell lines , 2013, Cancer Cell International.

[18]  A. Melcher,et al.  Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  Atsushi Hirao,et al.  Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence. , 2013, Cancer cell.

[20]  K. Tsuchihashi,et al.  xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma. , 2013, Cancer research.

[21]  D. Corbeil,et al.  CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges , 2013, The Journal of pathology.

[22]  W. Telford,et al.  CD200-expressing human basal cell carcinoma cells initiate tumor growth , 2013, Proceedings of the National Academy of Sciences.

[23]  B. Ebert,et al.  Implantable microenvironments to attract hematopoietic stem/cancer cells , 2012, Proceedings of the National Academy of Sciences.

[24]  D. Ballon,et al.  Orthotopic glioblastoma stem-like cell xenograft model in mice to evaluate intra-arterial delivery of bevacizumab: From bedside to bench , 2012, Journal of Clinical Neuroscience.

[25]  C. Cordon-Cardo,et al.  Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. , 2012, Cancer cell.

[26]  M. Bartucci,et al.  DNA Damage Repair Pathways in Cancer Stem Cells , 2012, Molecular Cancer Therapeutics.

[27]  H. Kleinman,et al.  Increased initiation and growth of tumor cell lines, cancer stem cells and biopsy material in mice using basement membrane matrix protein (Cultrex or Matrigel) co-injection , 2012, Nature Protocols.

[28]  Yang Jiang,et al.  Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer , 2012, Gastric Cancer.

[29]  S. Rosenberg,et al.  CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma , 2012, Clinical Cancer Research.

[30]  Jens-Peter Volkmer,et al.  Three differentiation states risk-stratify bladder cancer into distinct subtypes , 2012, Proceedings of the National Academy of Sciences.

[31]  P. Steeg,et al.  Notch1 Inhibition Alters the CD44hi/CD24lo Population and Reduces the Formation of Brain Metastases from Breast Cancer , 2011, Molecular Cancer Research.

[32]  B. Aggarwal,et al.  NF-κB addiction and its role in cancer: ‘one size does not fit all’ , 2011, Oncogene.

[33]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[34]  M. Ohmura,et al.  CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. , 2011, Cancer cell.

[35]  Ash A. Alizadeh,et al.  Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker , 2011, Proceedings of the National Academy of Sciences.

[36]  A. Wong,et al.  Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme. , 2010, Current opinion in molecular therapeutics.

[37]  James W. Tung,et al.  Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties , 2010, PloS one.

[38]  Raymond Sawaya,et al.  Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  J. Medema,et al.  Molecular identification and targeting of colorectal cancer stem cells , 2010, Oncotarget.

[40]  I. Weissman,et al.  Cancer stem cells in bladder cancer: a revisited and evolving concept , 2010, Current opinion in urology.

[41]  Sharmila Shankar,et al.  Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer , 2010, Journal of molecular signaling.

[42]  L. Chin,et al.  Non-germline genetically engineered mouse models for translational cancer research , 2010, Nature Reviews Cancer.

[43]  A. Merchant,et al.  Targeting Hedgehog — a Cancer Stem Cell Pathway , 2010, Clinical Cancer Research.

[44]  R. Nusse,et al.  Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. , 2010, Cell stem cell.

[45]  B. Vonderhaar,et al.  CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer. , 2010, Cancer research.

[46]  Irving L. Weissman,et al.  Human Melanoma Initiating Cells Express Neural Crest Nerve Growth Factor Receptor CD271 , 2010, Nature.

[47]  R. McLendon,et al.  Integrin alpha 6 regulates glioblastoma stem cells. , 2010, Cell stem cell.

[48]  Louis Vermeulen,et al.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.

[49]  O. Ohara,et al.  Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells , 2010, Science Translational Medicine.

[50]  R. Grossman,et al.  HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors , 2010, Clinical Cancer Research.

[51]  L. Chin,et al.  Chimeric mouse tumor models reveal differences in pathway activation between ERBB family– and KRAS-dependent lung adenocarcinomas , 2010, Nature Biotechnology.

[52]  L. Parada,et al.  Signaling in Malignant Astrocytomas: Role of Neural Stem Cells and Its Therapeutic Implications , 2009, Clinical Cancer Research.

[53]  Robert A. Gatenby,et al.  Environment-mediated drug resistance: a major contributor to minimal residual disease , 2009, Nature Reviews Cancer.

[54]  Jeffrey M. Rosen,et al.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.

[55]  Howard Y. Chang,et al.  Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells , 2009, Proceedings of the National Academy of Sciences.

[56]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[57]  Ash A. Alizadeh,et al.  CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells , 2009, Cell.

[58]  L. Chin,et al.  High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. , 2009, Blood.

[59]  J. Dick,et al.  Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells. , 2009, Cell stem cell.

[60]  D. Choi,et al.  Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. , 2009, World journal of gastroenterology.

[61]  T. Wang,et al.  Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44 , 2009, Stem cells.

[62]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[63]  I. Weissman,et al.  Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation , 2009, Proceedings of the National Academy of Sciences.

[64]  M. Dean.  ABC Transporters, Drug Resistance, and Cancer Stem Cells , 2009, Journal of Mammary Gland Biology and Neoplasia.

[65]  P. Febbo,et al.  Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. , 2009, Cancer cell.

[66]  P. Schultz,et al.  The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations , 2009, Proceedings of the National Academy of Sciences.

[67]  Jack J. Jiang,et al.  In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep‐2 cell line , 2009, Head & neck.

[68]  Angela C. Colmone,et al.  Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells , 2008, Science.

[69]  S. Morrison,et al.  Efficient tumor formation by single human melanoma cells , 2008, Nature.

[70]  J. Visvader,et al.  The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. , 2008, Cancer research.

[71]  Curt Balch,et al.  Identification and characterization of ovarian cancer-initiating cells from primary human tumors. , 2008, Cancer research.

[72]  M. Mullendore,et al.  Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer , 2008, Gut.

[73]  M. Biffoni,et al.  Identification and expansion of the tumorigenic lung cancer stem cell population , 2008, Cell Death and Differentiation.

[74]  Sean J. Morrison,et al.  Stem Cells and Niches: Mechanisms That Promote Stem Cell Maintenance throughout Life , 2008, Cell.

[75]  B. Clurman,et al.  FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation , 2008, Nature Reviews Cancer.

[76]  Mohamed H. Sayegh,et al.  Identification of cells initiating human melanomas , 2008, Nature.

[77]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[78]  Satoshi Tanaka,et al.  Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region , 2007, Nature Biotechnology.

[79]  A. Olivi,et al.  Cyclopamine‐Mediated Hedgehog Pathway Inhibition Depletes Stem‐Like Cancer Cells in Glioblastoma , 2007, Stem cells.

[80]  C. Heeschen,et al.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.

[81]  I. Weissman,et al.  CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia , 2007, Proceedings of the National Academy of Sciences.

[82]  Stephen Lam,et al.  Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. , 2007, Cancer research.

[83]  Ben Scheres,et al.  Stem-cell niches: nursery rhymes across kingdoms , 2007, Nature Reviews Molecular Cell Biology.

[84]  Alexander Brawanski,et al.  CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. , 2007, Cancer research.

[85]  J. Dick,et al.  Modeling the Initiation and Progression of Human Acute Leukemia in Mice , 2007, Science.

[86]  D. Hicklin,et al.  Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. , 2007, Cancer research.

[87]  I. Fidler,et al.  Murine models to evaluate novel and conventional therapeutic strategies for cancer. , 2007, The American journal of pathology.

[88]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[89]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[90]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[91]  R. Xiang,et al.  Characterization of stem cell-like cancer cells in immune-competent mice. , 2006, Blood.

[92]  J. Bansard,et al.  Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Rα2, gp100 and TRP-2 for immunotherapy , 2006, Journal of Neuro-Oncology.

[93]  J. Dick,et al.  Targeting of CD44 eradicates human acute myeloid leukemic stem cells , 2006, Nature Medicine.

[94]  S. Cole,et al.  Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. , 2006, Physiological reviews.

[95]  H. Li,et al.  Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells , 2006, Oncogene.

[96]  G. V. van Dongen,et al.  The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. , 2005, Blood.

[97]  P. Dalerba,et al.  Identification of pancreatic cancer stem cells. , 2006, Cancer research.

[98]  D. Elder,et al.  A tumorigenic subpopulation with stem cell properties in melanomas. , 2005, Cancer research.

[99]  I. Weissman,et al.  Stem cell research: paths to cancer therapies and regenerative medicine. , 2005, JAMA.

[100]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[101]  M. Mandal,et al.  An Orthotopic Model of Anaplastic Thyroid Carcinoma in Athymic Nude Mice , 2005, Clinical Cancer Research.

[102]  M. Kotb,et al.  Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12 , 2004, The Journal of Immunology.

[103]  G. Dontu,et al.  Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells , 2004, Breast Cancer Research.

[104]  Keisuke Ito,et al.  Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche , 2004, Cell.

[105]  K. Nakayama,et al.  Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7 , 2004, The EMBO journal.

[106]  K. Aldape,et al.  Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR , 2004, Genes, chromosomes & cancer.

[107]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[108]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[109]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[110]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[111]  I. Weissman,et al.  Telomerase Activation and Rejuvenation of Telomere Length in Stimulated T Cells Derived from Serially Transplanted Hematopoietic Stem Cells , 2002, The Journal of experimental medicine.

[112]  Mamoru Ito,et al.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. , 2002, Blood.

[113]  Irving L. Weissman,et al.  Prospective isolation of human clonogenic common myeloid progenitors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[114]  I. Weissman,et al.  Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. , 2002, The Journal of clinical investigation.

[115]  I. Weissman,et al.  Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role? , 2002, Oncogene.

[116]  T. Jacks,et al.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.

[117]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[118]  I. Weissman,et al.  Telomere Shortening Accompanies Increased Cell Cycle Activity during Serial Transplantation of Hematopoietic Stem Cells , 2001, The Journal of experimental medicine.

[119]  I. Weissman,et al.  AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[120]  I. Weissman,et al.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.

[121]  D. van der Kooy,et al.  Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. , 1999, Developmental biology.

[122]  I. Weissman,et al.  Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. , 1998, Immunity.

[123]  I. Weissman,et al.  Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.

[124]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[125]  I. Weissman,et al.  Identification of a lineage of multipotent hematopoietic progenitors. , 1997, Development.

[126]  C. E. Dinsmore.  Animal regeneration—from fact to concept , 1995 .

[127]  I. Weissman,et al.  The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. , 1994, Immunity.

[128]  I. Roninson,et al.  Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. , 1993, Journal of the National Cancer Institute.

[129]  I. Roninson,et al.  Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. , 1992, Blood.

[130]  J. Aubin,et al.  Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitro. , 1989, Developmental biology.

[131]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[132]  H. Breivik.  Haematopoietic stem cell content of murine bone marrow, spleen, and blood. Limiting dilution analysis of diffusion chamber cultures , 1971, Journal of cellular physiology.

[133]  F. Dixon,et al.  The biology of testicular cancer. I. Behavior after transplantation. , 1957, Cancer research.

[134]  C. Waddington,et al.  GENETIC ASSIMILATION OF THE BITHORAX PHENOTYPE , 1956 .

[135]  H. Scherer.  A CRITICAL REVIEW , 1940, Journal of neurology and psychiatry.

[136]  B. Ruggeri,et al.  Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery. , 2014, Biochemical pharmacology.

[137]  L. Álvarez-Vallina,et al.  Engineered human tumor xenografts with functional human vascular networks. , 2011, Microvascular research.

[138]  R. Clarke,et al.  Tumor and Stem Cell Biology Cancer Research Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch 4 Receptor , 2010 .

[139]  C. Huff,et al.  Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. , 2008, Cancer research.

[140]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[141]  C. Branda,et al.  Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. , 2004, Developmental cell.